Xu Cuiping, Yu Tao, Zhang Guojun, Wang Yuping, Li Yongjie
Department of Functional Neurosurgery, Xuanwu Hospital, Capital Medical University, Beijing, China; Beijing Institute of Functional Neurosurgery, Xuanwu Hospital, Capital Medical University, Beijing, China.
Department of Functional Neurosurgery, Xuanwu Hospital, Capital Medical University, Beijing, China; Beijing Institute of Functional Neurosurgery, Xuanwu Hospital, Capital Medical University, Beijing, China.
World Neurosurg. 2019 Jan;121:e32-e38. doi: 10.1016/j.wneu.2018.08.192. Epub 2018 Sep 3.
We aimed to investigate the possible predictive factors and longitudinal change in long-term surgical outcome after refractory frontal lobe epilepsy surgery.
We retrospectively reviewed 82 patients who underwent frontal lobe resection. Invasive monitoring was performed in 43 patients. All patients were followed-up for a minimum of 3 years after surgery. Univariate and multivariate analyses were used to evaluate the predictors. The Kaplan-Meier survival curve showed the estimated probability of complete seizure freedom, and a favorable outcome was defined as Engel class I at the last follow-up.
The estimated probability of complete seizure freedom was 57.3% at 1 year postoperatively, 51.2% at 2 years, and 50.0% at 5 years. Factors predictive of worse long-term outcome were lack of a lesion in the frontal lobe on magnetic resonance imaging, generalized/nonlocalized ictal discharge, use of subdural grids, and acute postoperative seizure (APOS). After the surgery, 44 patients (53.7%) had seizures at any time during the first 2 years. Five of 44 patients had seizure freedom at the last follow-up. After a seizure-free period of at least 6 months, seizure recurred in 6 patients by 6 months to 1 year (early recurrence) and in 9 patients by 1-3 years (late recurrence). Eight of 43 (18.6%) seizure-free patients had discontinued drugs.
The overall seizure outcome after surgery changed most during the first 2 years. The presence of frontal focal lesions and ictal frontal rhythm predicted favorable outcome. However, APOS was predictive of early epilepsy recurrence.
我们旨在研究难治性额叶癫痫手术后长期手术效果的可能预测因素及纵向变化。
我们回顾性分析了82例行额叶切除术的患者。43例患者进行了侵入性监测。所有患者术后至少随访3年。采用单因素和多因素分析评估预测因素。Kaplan-Meier生存曲线显示了完全无癫痫发作的估计概率,末次随访时将Engel I级定义为良好结局。
术后1年完全无癫痫发作的估计概率为57.3%,2年时为51.2%,5年时为50.0%。预测长期预后较差的因素包括磁共振成像显示额叶无病变、全身性/非局限性发作期放电、使用硬膜下网格电极以及急性术后癫痫发作(APOS)。术后,44例患者(53.7%)在术后前2年内的任何时间出现癫痫发作。44例患者中有5例在末次随访时无癫痫发作。在至少6个月的无癫痫发作期后,6例患者在6个月至1年时癫痫复发(早期复发),9例患者在1至3年时癫痫复发(晚期复发)。43例无癫痫发作患者中有8例(18.6%)停药。
术后癫痫总体结局在术后前2年变化最大。额叶局灶性病变和发作期额叶节律提示预后良好。然而,APOS是早期癫痫复发的预测因素。